DE:G11 Stock Latest News
Company AnnouncementsPharmaDrug Takes 19.9% Stake in Canurta and Restructures Capital to Advance Botanical Drug Portfolio10M ago
Company AnnouncementsPharmaDrug Inc. Announces Debt Restructuring to Strengthen Financial Position1y ago
Company AnnouncementsPharmaDrug to Acquire 40% Stake in Canurta Inc., Expanding Biotech Footprint1y ago
Company AnnouncementsPharmaDrug Corrects Share Issuance in Canurta Acquisition Deal1y ago
Company AnnouncementsPharmaDrug to Acquire 40% Stake in Biotech Firm Canurta1y ago
Company AnnouncementsPharmaDrug Announces CEO Resignation and Leadership Transition1y ago
Company AnnouncementsPharmaDrug Debenture Units Issuance Announcement2y ago
Company AnnouncementsPharmaDrug Advances PD-001 for Clinical Trials2y ago- Company AnnouncementsPharmaDrug Begins Clinical Trial for Infectious Disease Treatment2y ago
- Company AnnouncementsPharmaDrug Advances PD-001 in Fight Against Viral Diseases2y ago
Company AnnouncementsPharmaDrug’s Cepharanthine Shows Potential Against Monkeypox2y ago
Company AnnouncementsPharmaDrug Advances Clinical Trials for PD-0012y ago
Company AnnouncementsPharmaDrug Innovates in Biosynthetic Cocaine Market2y ago- Company AnnouncementsPharmaDrug Welcomes New Board Member2y ago
- Company AnnouncementsPharmaDrug Advances with PD-001 Clinical Trials2y ago
Company AnnouncementsPharmaDrug Innovates in Biosynthetic Cocaine Production2y ago
